News Grower

Independent coverage of AI, startups, and technology.

Ars Technica Mar 31, 2026 at 21:51 Big Tech Stable Warm

RFK Jr. wants Americans to use peptides that were banned over safety risks

The FDA is reportedly planning to allow production of 14 previously banned peptides.

Signal weather

Stable

The story has moved beyond the first headline and now acts as a reliable context anchor.

By Beth Mole Original source
RFK Jr. wants Americans to use peptides that were banned over safety risks

Anti-vaccine Health Secretary Robert F. Kennedy Jr.—who has long dismissed reams of data on lifesaving vaccines as being insufficient to prove safety—is pushing the Food and Drug Administration to lift restrictions on over a dozen injectable peptide treatments. The treatments have little to no efficacy data behind them and were previously banned by the FDA for posing significant safety risks. Kennedy is a self-proclaimed "big fan" of the risky treatments. Peptides, generally, are chains of amino acids linked together with peptide bonds, a link between the carboxyl group of one amino acid and the amino group of another. Bioactive peptides can have a range of cellular functions and influence various biochemical processes. Well-established, FDA-approved types of peptide drugs include GLP-1s for obesity and insulin for diabetes. But online, peptide drugs are now seemingly synonymous with unproven, non-FDA-approved treatment. They've grown extremely popular among wellness influencers, celebrities, and "biohackers," who claim without evidence that peptides can treat various diseases, reverse aging, and improve appearance. On February 27, Kennedy touted such unproven peptides as a guest on Joe Rogan's podcast, saying he had used them to treat injuries with "really good effect." He also vowed to end the FDA's "war on peptides" and revealed his plan to reverse the FDA's restrictions on many of them. Read full article Comments

Stay on the signal

Follow RFK Jr. wants Americans to use peptides that were banned over safety risks

Follow this story beyond a single article: new follow-ups, adjacent sources, and the evolving storyline.

We send a confirmation link first, then only meaningful digests.

Story map

Understand this topic fast

A quick entry into the story: why it matters now, who is involved, and where to go next for context.

Why it matters now

This story is still moving and pulling follow-up coverage.
There are already 6 connected articles in the same storyline to continue from here.
The story keeps orbiting around Americans, Ars Technica, and Banned, so the entity pages are the fastest way to build context.
Ars Technica already has 4 follow-up stories on the same theme.

Topic constellation

Open the live map for this story

See which entities, story threads, sources, and follow-up articles shape this story right now.

Click nodes to continue

Entity Cluster Article Hub Source

Story timeline

Continue with this story

A short sequence of events and follow-up stories to understand the arc quickly.

May 17, 2026 at 11:00 Ars Technica

A revolutionary cancer treatment could transform autoimmune disease

Researchers are testing CAR T cell therapy as a way to reset the immune system.

May 16, 2026 at 11:00 Ars Technica

The US is betting on AI to catch insider trading in prediction markets

The Commodity Futures Trading Commission wants us to know it's taking this very seriously.

May 15, 2026 at 22:19 Ars Technica

Russia pressures university students to become wartime drone pilots

Universities promise no frontline duty and perks if students enlist in military.

May 15, 2026 at 21:51 Ars Technica

Anthropic’s $1.5B copyright settlement is getting messy as judge delays approval

Lawyers accused of rushing historic settlement to seize $320 million in fees.

May 15, 2026 at 21:31 Ars Technica

US hantavirus case was false positive; outbreak cases drop from 11 to 10

WHO announced today that the operation to safely transfer passengers is complete.

Mar 31, 2026 at 21:51 Ars Technica

RFK Jr. wants Americans to use peptides that were banned over safety risks

The FDA is reportedly planning to allow production of 14 previously banned peptides.

How reliable this looks

Signal and trust for Ars Technica

This source works at a rapid pace: 100% of recent stories land in the hot window, and 0% carry visible search signal.

Trusted

Reliability

92

Freshness

100

Sources in storyline

1

Related articles

More stories that share tags, source, or category context.

More from Ars Technica

Fresh reporting and follow-up coverage from the same newsroom.

Open source page